BGI Genomics Co., Ltd. (SHE:300676)
China flag China · Delayed Price · Currency is CNY
53.23
+2.17 (4.25%)
Sep 8, 2025, 11:42 AM CST

BGI Genomics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Operating Revenue
3,6003,8424,3337,0366,7548,387
Upgrade
Other Revenue
26.5724.616.9116.6711.7510.31
Upgrade
3,6273,8674,3507,0536,7668,397
Upgrade
Revenue Growth (YoY)
-12.59%-11.10%-38.33%4.24%-19.42%199.86%
Upgrade
Cost of Revenue
2,2842,3642,2023,5282,8453,382
Upgrade
Gross Profit
1,3431,5032,1473,5263,9215,015
Upgrade
Selling, General & Admin
1,3351,4241,4411,9981,6371,630
Upgrade
Research & Development
578.74601.38523.23526.46474.79611.32
Upgrade
Other Operating Expenses
16.0716.774.1-8924.06-10.23
Upgrade
Operating Expenses
2,1812,2402,0352,6202,2412,372
Upgrade
Operating Income
-838.16-736.53112.94905.271,6802,643
Upgrade
Interest Expense
-29.98-52.02-91.56-100.76-104.72-89.04
Upgrade
Interest & Investment Income
121.2125.72153.33424.36218.16119.22
Upgrade
Currency Exchange Gain (Loss)
20.32-19.09-11.36-2.27-39.76-138.51
Upgrade
Other Non Operating Income (Expenses)
-9.54-3.41-35.86-91.43-4.04-35.45
Upgrade
EBT Excluding Unusual Items
-736.15-685.33127.491,1351,7502,499
Upgrade
Impairment of Goodwill
-10.64-10.64----
Upgrade
Gain (Loss) on Sale of Investments
-60.01-87.41-34.3680.7386.4152.2
Upgrade
Gain (Loss) on Sale of Assets
-5.1-0.632.760.11-3.88-4.23
Upgrade
Asset Writedown
-124.85-125.97-9.25-209.24-102.24-105.02
Upgrade
Other Unusual Items
11.9823.8628.890.0215.870
Upgrade
Pretax Income
-924.76-886.11115.541,0071,7462,442
Upgrade
Income Tax Expense
3.3525.9921.85197.51268.19340.24
Upgrade
Earnings From Continuing Operations
-928.11-912.193.68809.291,4782,102
Upgrade
Minority Interest in Earnings
139.41-0.78-6.52-16.16-11.77
Upgrade
Net Income
-915.11-902.6992.9802.771,4622,090
Upgrade
Preferred Dividends & Other Adjustments
-----1.4
Upgrade
Net Income to Common
-915.11-902.6992.9802.771,4622,089
Upgrade
Net Income Growth
---88.43%-45.07%-30.08%656.43%
Upgrade
Shares Outstanding (Basic)
410412410410410398
Upgrade
Shares Outstanding (Diluted)
410412412410412399
Upgrade
Shares Change (YoY)
-1.73%0.01%0.48%-0.32%3.11%-0.20%
Upgrade
EPS (Basic)
-2.23-2.190.231.963.565.25
Upgrade
EPS (Diluted)
-2.23-2.190.231.963.555.24
Upgrade
EPS Growth
---88.48%-44.90%-32.25%658.65%
Upgrade
Free Cash Flow
-822.91-433.76-827.62-1,1362,0933,302
Upgrade
Free Cash Flow Per Share
-2.01-1.05-2.01-2.775.088.27
Upgrade
Dividend Per Share
--0.1001.0000.3500.350
Upgrade
Dividend Growth
---90.00%185.71%-250.00%
Upgrade
Gross Margin
37.03%38.87%49.37%49.99%57.95%59.72%
Upgrade
Operating Margin
-23.11%-19.05%2.60%12.83%24.83%31.48%
Upgrade
Profit Margin
-25.23%-23.34%2.14%11.38%21.60%24.88%
Upgrade
Free Cash Flow Margin
-22.69%-11.22%-19.03%-16.10%30.93%39.32%
Upgrade
EBITDA
-424.06-320.95482.761,2621,9592,945
Upgrade
EBITDA Margin
-11.69%-8.30%11.10%17.90%28.95%35.08%
Upgrade
D&A For EBITDA
414.09415.57369.81357.13278.78302.33
Upgrade
EBIT
-838.16-736.53112.94905.271,6802,643
Upgrade
EBIT Margin
-23.11%-19.05%2.60%12.83%24.83%31.48%
Upgrade
Effective Tax Rate
--18.92%19.62%15.36%13.93%
Upgrade
Revenue as Reported
3,6273,8674,3507,0536,766-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.